Coagulación intravascular diseminada en el paciente con sepsis

Palabras clave: coagulación intravascular diseminada, sepsis, fallo multiorgánico, anticoagulante

Resumen

La sepsis es un proceso infeccioso altamente inflamatorio que se asocia con una incidencia importante de mortalidad y múltiples complicaciones. Una de estas complicaciones es la coagulación intravascular diseminada que se desarrolla en casi la mitad de los pacientes con sepsis. Esta tiene como una de sus consecuencias finales la falla orgánica múltiple, por lo cual no es extraño que la tasa de mortalidad de un paciente con sepsis y coagulación intravascular diseminada sea relativamente alta. La patogénesis de la coagulación intravascular diseminada puede ser atribuida a un trastorno de coagulación iniciado por el factor tisular, con diseminación de micro coágulos y consumo acelerado de factores de coagulación. Tiene entonces como resultado, la falla orgánica múltiple, diferentes trastornos hemorrágicos y en los peores casos, la muerte. El manejo actual de la coagulación intravascular diseminada está dirigido a tratar la enfermedad subyacente, en este caso el agente patógeno, además del tratamiento anticoagulante de soporte para mejorar los resultados clínicos.

Estadistica de descarga del artículo

Cargando métricas ...

Biografía del autor/a

Dra. Alejandra Maya Cancino , Investigadora independiente, San José, Costa Rica

Médica general, graduada de la Universidad de Ciencias Medicas (UCIMED). cod. MED16129. Correo: alemaya94@gmail.com

Dra. Astrid Carolina Cartín Ramírez , Autism Awareness Costa Rica, San José, Costa Rica

Médica general, graduada de la Universidad de Ciencias Medicas (UCIMED). cod. MED16085. Correo: dracartinr@gmail.com

Dra. María del Sol Osejo Rodríguez , Investigadora independiente, San José, Costa Rica

Médica general, graduada de la Universidad de Ciencias Medicas (UCIMED). Cod. MED16143 Correo: sol_osejo@hotmail.com

Citas

ba T, Ito T, Maruyama I, Jilma B, Brenner T, Müller MC, et al. Potential diagnostic markers for disseminated intravascular coagulation of sepsis. Blood Reviews. 2016;30(2):149–55. https://doi.org/10.1016/j.blre.2015.10.002

Iba T, Thachil J. Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan. International Journal of Hematology. 2015Nov20;103(3):253–61. https://doi.org/10.1007/s12185-015-1904-z

T, Shoko T, Deguchi Y. Clinical Investigation of Coagulation Markers for Early Detection of Sepsis-Induced Disseminated Intravascular Coagulation: A Single-Center, Prospective Observational Study. Clinical and Applied Thrombosis/Hemostasis. 2018Mar18;24(7):1082–7. https://doi.org/10.1177/1076029618762473

Tsao C-M, Ho S-T, Wu C-C. Coagulation abnormalities in sepsis. Acta Anaesthesiologica Taiwanica. 2015;53(1):16–22. https://doi.org/10.1016/j.aat.2014.11.002

Park JY, Park S, Park SY, Sim YS, Kim JH, Hwang YI, et al. Day 3 versus Day 1 Disseminated Intravascular Coagulation Score among Sepsis Patients: A Prospective Observational Study. Anaesthesia and Intensive Care. 2016Jan;44(1):57–64. https://doi.org/10.1177/0310057X1604400110

Kudo D, Hayakawa M, Ono K, Yamakawa K. Impact of non-anticoagulant therapy on patients with sepsis-induced disseminated intravascular coagulation: A multicenter, case-control study. Thrombosis Research. 2018;163:22–9. https://doi.org/10.1016/j.thromres.2017.12.022

Kudo D, Hayakawa M, Ono K, Yamakawa K. Impact of non-anticoagulant therapy on patients with sepsis-induced disseminated intravascular coagulation: A multicenter, case-control study. Thrombosis Research. 2018;163:22–9. https://doi.org/10.1016/j.thromres.2017.12.022

Levi M. Pathogenesis and diagnosis of disseminated intravascular coagulation. International Journal of Laboratory Hematology. 2018;40:15–20. https://doi.org/10.1111/ijlh.12830

Levi M, Sivapalaratnam S. Disseminated intravascular coagulation: an update on pathogenesis and diagnosis. Expert Review of Hematology. 2018Jul20;11(8):663–72. https://doi.org/10.1080/17474086.2018.1500173

Umemura Y, Yamakawa K. Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials: reply. Journal of Thrombosis and Haemostasis. 2016;14(11):2310–1. https://doi.org/10.1111/jth.13473

Thachil J. Disseminated intravascular coagulation – new pathophysiological concepts and impact on management. Expert Review of Hematology. 2016Jun17;9(8):803–14. https://doi.org/10.1080/17474086.2016.1203250

Okuda A, Ogura T, Imanishi M, Miyano A, Nishioka N, Higuchi K. Clinical Impact of Recombinant Soluble Thrombomodulin for Disseminated Intravascular Coagulation Associated with Severe Acute Cholangitis. Gut and Liver. 2018Jul15;12(4):471–7. https://doi.org/10.5009/gnl17489

Iba T, Thachil J. Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan. International Journal of Hematology. 2015Nov20;103(3):253–61. https://doi.org/10.1007/s12185-015-1904-z

Ikeda M, Matsumoto H, Ogura H, Hirose T, Shimizu K, Yamamoto K, et al. Circulating syndecan-1 predicts the development of disseminated intravascular coagulation in patients with sepsis. Journal of Critical Care. 2018Feb;43:48–53. https://doi.org/10.1016/j.jcrc.2017.07.049

Walborn A, Rondina M, Mosier M, Fareed J, Hoppensteadt D. Endothelial Dysfunction Is Associated with Mortality and Severity of Coagulopathy in Patients with Sepsis and Disseminated Intravascular Coagulation. Clinical and Applied Thrombosis/Hemostasis. 2019;25:107602961985216. https://doi.org/10.1177/1076029619852163

Levi M, van der Poll T. Coagulation and sepsis. Thrombosis Research. 2016Nov19;149:38–44. https://doi.org/10.1016/j.thromres.2016.11.007

Delabranche X, Quenot J-P, Lavigne T, Mercier E, François B, Severac F, et al. Early Detection of Disseminated Intravascular Coagulation During Septic Shock. Critical Care Medicine. 2016;44(10). https://doi.org/10.1097/CCM.0000000000001836

Umemura Y, Yamakawa K, Hayakawa M, Kudo D, Fujimi S. Concomitant Versus Individual Administration of Antithrombin and Thrombomodulin for Sepsis-Induced Disseminated Intravascular Coagulation: A Nationwide Japanese Registry Study. Clinical and Applied Thrombosis/Hemostasis. 2018Feb22;24(5):734–40. https://doi.org/10.1177/1076029618755948

Hayakawa M, Yamakawa K, Kudo D, Ono K. Optimal Antithrombin Activity Threshold for Initiating Antithrombin Supplementation in Patients With Sepsis-Induced Disseminated Intravascular Coagulation: A Multicenter Retrospective Observational Study. Clinical and Applied Thrombosis/Hemostasis. 2018Aug;24(6):874–83. https://doi.org/10.1177/1076029618757346

Akahoshi T, Sugimori H, Kaku N, Tokuda K, Nagata T, Noda E, et al. Comparison of recombinant human thrombomodulin and gabexate mesylate for treatment of disseminated intravascular coagulation (DIC) with sepsis following emergent gastrointestinal surgery: a retrospective study. European Journal of Trauma and Emergency Surgery. 2014Nov20;41(5):531–8. https://doi.org/10.1007/s00068-014-0478-4

Umemura Y, Yamakawa K, Hayakawa M, Hamasaki T, Fujimi S. Screening itself for disseminated intravascular coagulation may reduce mortality in sepsis: A nationwide multicenter registry in Japan. Thrombosis Research. 2018;161:60–6. https://doi.org/10.1016/j.thromres.2017.11.023

Publicado
2020-07-01
Cómo citar
1.
Maya Cancino A, Cartín Ramírez AC, Osejo Rodríguez M del S. Coagulación intravascular diseminada en el paciente con sepsis . Rev.méd.sinerg. [Internet]. 1 de julio de 2020 [citado 11 de agosto de 2020];5(7):e388. Disponible en: https://revistamedicasinergia.com/index.php/rms/article/view/388
Sección
Artículos de Revisión

Artículos más leídos del mismo autor/a